Controlled Clinical TrialiVNSn = 28

Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus

Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, et al.

Journal of Obesity · 2013

Key finding

In 28 obese subjects with type 2 diabetes, open-label vagal blocking therapy produced 25% excess weight loss and a 1.0% reduction in HbA1c at 12 months.

Condition
Obesity
Stimulation
iVNS
Evidence tier
Controlled Clinical Trial
Participants
28
View on DOI

Cite this study

Shikora, S., Toouli, J., Herrera, M. F., Kulseng, B., Zulewski, H., Brancatisano, R., Kow, L., Pantoja, J. P., Johnsen, G., Brancatisano, A., Tweden, K. S., Knudson, M. B., & Billington, C. J. (2013). Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. Journal of Obesity, 2013, 1-8. https://doi.org/10.1155/2013/245683

Related studies in Obesity

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.